4D Molecular Therapeutics
FDMT
#7429
Rank
A$0.64 B
Marketcap
A$11.37
Share price
0.92%
Change (1 day)
52.50%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for 4D Molecular Therapeutics CIK: 0001650648

Thumbnail 4D Molecular Therapeutics 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail 4D Molecular Therapeutics 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail 4D Molecular Therapeutics 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail 4D Molecular Therapeutics 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail 4D Molecular Therapeutics 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)